[{"address1": "999 West Broadway", "address2": "Suite 720", "city": "Vancouver", "state": "BC", "zip": "V5Z 1K5", "country": "Canada", "phone": "778 331 0962", "website": "https://www.essapharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.", "fullTimeEmployees": 50, "maxAge": 86400, "priceHint": 4, "previousClose": 4.98, "open": 5.13, "dayLow": 4.72, "dayHigh": 5.15, "regularMarketPreviousClose": 4.98, "regularMarketOpen": 5.13, "regularMarketDayLow": 4.72, "regularMarketDayHigh": 5.15, "beta": 1.816, "forwardPE": -4.8039217, "volume": 50243, "regularMarketVolume": 50243, "averageVolume": 63462, "averageVolume10days": 84880, "averageDailyVolume10Day": 84880, "bid": 4.72, "ask": 5.02, "bidSize": 100, "askSize": 100, "marketCap": 217378704, "fiftyTwoWeekLow": 2.58, "fiftyTwoWeekHigh": 11.67, "fiftyDayAverage": 6.2058, "twoHundredDayAverage": 6.34899, "currency": "USD", "enterpriseValue": 81843648, "floatShares": 25755378, "sharesOutstanding": 44363000, "sharesShort": 913125, "sharesShortPriorMonth": 769263, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.020599999, "heldPercentInsiders": 0.0227, "heldPercentInstitutions": 0.79116994, "shortRatio": 16.81, "shortPercentOfFloat": 0.0342, "impliedSharesOutstanding": 44363000, "bookValue": 3.009, "priceToBook": 1.628448, "lastFiscalYearEnd": 1696032000, "nextFiscalYearEnd": 1727654400, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -27734080, "trailingEps": -0.63, "forwardEps": -1.02, "lastSplitFactor": "1:20", "lastSplitDate": 1524614400, "52WeekChange": 0.6896552, "SandP52WeekChange": 0.26238096, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "EPIX", "underlyingSymbol": "EPIX", "shortName": "ESSA Pharma Inc.", "longName": "ESSA Pharma Inc.", "firstTradeDateEpochUtc": 1426253400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "df985973-70f3-3299-9207-8f4fc74eed04", "messageBoardId": "finmb_275296588", "gmtOffSetMilliseconds": -14400000, "currentPrice": 4.9, "targetHighPrice": 29.0, "targetLowPrice": 15.0, "targetMeanPrice": 19.0, "targetMedianPrice": 17.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 135888672, "totalCashPerShare": 3.063, "totalDebt": 353662, "quickRatio": 32.605, "currentRatio": 32.891, "debtToEquity": 0.265, "returnOnAssets": -0.14401, "returnOnEquity": -0.19139999, "freeCashflow": -15584652, "operatingCashflow": -22999026, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]